Literature DB >> 28698069

Theranostic and nanotheranostic probes in nuclear medicine.

Natascha Drude1, Lena Tienken2, Felix M Mottaghy3.   

Abstract

In nuclear medicine, a theranostic probe describes a substance that combines diagnostic and therapeutic capabilities by radiolabeling it with different radionuclides. Next to a brief description of the different emitters (α, β+, β-, γ) used for imaging and/or therapy, the aim of this review is to summarize the most commonly used theranostic probes in nuclear medicine. Another goal is to give an idea which chemical requirements need to be fulfilled for radiolabeling with either therapeutic and/or diagnostic relevant nuclides. Furthermore, a perspective is given into the field of nanotheranostics which is gaining more and more attention in nuclear medicine. The combination has been called radionanomedicine and is a very proliferative field with an enormous potential.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Molecular imaging; Nanotheranostic; Radionanomedicine; Radiotherapy; Theranostic

Mesh:

Substances:

Year:  2017        PMID: 28698069     DOI: 10.1016/j.ymeth.2017.07.004

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  8 in total

1.  Radiolabeling of Theranostic Nanosystems.

Authors:  Sudeep Das; Surachet Imlimthan; Anu J Airaksinen; Mirkka Sarparanta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Surface-Modified Shortwave-Infrared-Emitting Nanophotonic Reporters for Gene-Therapy Applications.

Authors:  Zhenghuan Zhao; Harini Kantamneni; Shuqing He; Sandra Pelka; Aiyer Sandhya Venkataraman; Mijung Kwon; Steven K Libutti; Mark Pierce; Prabhas V Moghe; Vidya Ganapathy; Mei Chee Tan
Journal:  ACS Biomater Sci Eng       Date:  2018-04-30

Review 3.  Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.

Authors:  Ján Kozempel; Olga Mokhodoeva; Martin Vlk
Journal:  Molecules       Date:  2018-03-05       Impact factor: 4.411

4.  Cross-Isotopic Bioorthogonal Tools as Molecular Twins for Radiotheranostic Applications.

Authors:  Veronika Rosecker; Christoph Denk; Melanie Maurer; Martin Wilkovitsch; Severin Mairinger; Thomas Wanek; Hannes Mikula
Journal:  Chembiochem       Date:  2019-05-08       Impact factor: 3.164

5.  The utility of PET/CT in large vessel vasculitis.

Authors:  Jennifer Ben Shimol; Howard Amital; Merav Lidar; Liran Domachevsky; Yehuda Shoenfeld; Tima Davidson
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

6.  18F[AlF]-radiolabelled Peptides on the Automated Synthesis Platform: Translating the Laboratory Bench Work to Bedside.

Authors:  Hishar Hassan; Hairil Rashmizal Abdul Razak; Fathinul Fikri Ahmad Saad; Vijay Kumar
Journal:  Malays J Med Sci       Date:  2019-08-29

Review 7.  Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.

Authors:  Cristina Barca; Christoph M Griessinger; Andreas Faust; Dominic Depke; Markus Essler; Albert D Windhorst; Nick Devoogdt; Kevin M Brindle; Michael Schäfers; Bastian Zinnhardt; Andreas H Jacobs
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22

Review 8.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.